Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Potential Impact of an Artificial Intelligence Solution in Second Reading of Organized Screening.

NCT06479772 is registered in ClinicalTrials.gov with GCS Ramsay Santé pour l'Enseignement et la Recherche as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06479772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Potential Impact of an Artificial Intelligence Solution in Second Reading of Organized Screening.
Lead sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Phase
Observational
Overall status
Completed
Start date
October 10, 2023
Completion date
March 31, 2024
Enrollment
55,589 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer female